Document is current
Any future updates will be listed below
-
Authors
Guo, Xiaoyi
Liang, Xu
Li, Ben
Mao, Yan
Zhou, Nina
Liu, Jiayue
Yang, Guangjie
Wang, Zhenguang
Song, Guohong
Yang, Zhi https://orcid.org/0000-0003-2084-5193
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82171980)
the Capital’s Funds for Health Improvement and Research (2022-2Z-2154)
the Pilot Project (4 th Round) to Reform Public Development of Beijing Municipal Medical Research Institute (2021-1)
and Science Foundation of Peking University Cancer Hospital (KC2305)
Isotope and Pharmaceutical Innovation Fund of National Engineering Research Center of Isotope & Pharmaceutical (B00167)
Nuclear energy development research project (2023)
- License Information
-
More Information
Article History
Received: 28 November 2024
Accepted: 26 March 2025
First Online: 10 April 2025
Declarations
:
: All procedures in this study were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and its later versions. Informed consent was, or its equivalent, was obtained from all patients included in the study. The clinical study was approved by the Ethics Committee of the Beijing Cancer Hospital (ethical approval no. 2019KT114). Nuclear energy development research project (2023).
: Informed consent was obtained from the 58 individual participants included in this study.
: The authors declare no potential conflicts of interest.
